UroGen Pharma Ltd. — SC 13G Filings
19 SC 13G filings on record
This page lists all SC 13G filings submitted to the SEC by UroGen Pharma Ltd. (URGN), sorted by most recent first. Each row links to the full filing on EdgarLookup. UroGen Pharma Ltd. has filed 19 SC 13G documents with the SEC since 2016. To view all SEC filings by UroGen Pharma Ltd., see the full filings list.
All
10-K
10-K/A
10-Q
144
20-F
3
3/A
4
4/A
424B4
424B5
6-K
8-A12B
8-K
ARS
CERTNAS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
F-1
F-1/A
F-1MEF
F-3
S-3
S-3/A
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SC 13G | UROGEN PHARMA LTD. | 0000902664-24-006395 | Nov 12, 2024 | — |
| SC 13G | — | 0002012383-24-003700 | Nov 8, 2024 | — |
| SC 13G | — | 0002012383-24-002179 | Oct 24, 2024 | — |
| SC 13G | UROGEN PHARMA LTD. | 0000902664-24-004451 | Jun 24, 2024 | — |
| SC 13G | COWEN AND COMPANY, LLC | 0001085146-24-002732 | Jun 24, 2024 | — |
| SC 13G | UROGEN PHARMA LTD. | 0000902664-24-001542 | Feb 14, 2024 | — |
| SC 13G | — | 0001086364-24-006217 | Feb 2, 2024 | — |
| SC 13G | SC 13G | 0001104659-23-130500 | Dec 29, 2023 | — |
| SC 13G | — | 0001172661-23-003255 | Sep 15, 2023 | — |
| SC 13G | — | 0000935836-22-000637 | Dec 1, 2022 | — |
| SC 13G | — | 0000834237-22-010336 | Jul 8, 2022 | — |
| SC 13G | NONE | 0001567619-21-003470 | Feb 12, 2021 | — |
| SC 13G | — | 0000834237-20-007990 | Feb 7, 2020 | — |
| SC 13G | ACQUISITION OF BENEFICIAL OWNERSHIP | 0001387131-19-007448 | Oct 4, 2019 | — |
| SC 13G | SEC SCHEDULE 13G | 0000902219-19-000060 | Feb 12, 2019 | — |
| SC 13G | CONSONANCE CAPITAL MANAGEMENT LP | 0001085146-18-000765 | Feb 14, 2018 | — |
| SC 13G | — | 0000315066-18-001612 | Feb 13, 2018 | — |
| SC 13G | SC 13G | 0001178913-17-003064 | Nov 8, 2017 | — |
| SC 13G | SC 13G | 0001144204-17-037493 | Jul 20, 2017 | — |